Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Babjuk M. Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer. Eur Urol 2024 Apr 9:S0302-2838(24)02262-0. doi: 10.1016/j.eururo.2024.
PMID: 38599993


Privacy Policy